CHI Robert Ballanger
Aulnay-sous-Bois, Île-de-France Region, 93600, France
Location contact
Fatima Le Griguer, psychologist
PRINCIPAL_INVESTIGATOR
Nour BEKOUCHE, Head manager
CONTACT
Not Yet Recruiting
NCT Number: NCT07578194
Coercive Control and Intimate Partner Violence
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.
The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.
Not Yet Recruiting
Trial opening soon.
Get NotifiedKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
- Women identified as victims of intimate partner violence.
- Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
- No objection to participation in the study (non-opposition).
- Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).
Exclusion criteria
- Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
- Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
- Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).
Treatment and study plan
Questionnaire
OtherParticipants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment
Primary outcomes
-
Coercive Control Screening Scale
Time frame: Measure of CCSS between inlusion and month 6
Measure of Coercive Control Screening Scale (CCSS). Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
Secondary outcomes
-
Measure of Hospital Anxiety and Depression scale (HAD scale)
Time frame: Measure of HHAD scale between inclusion and month 6
correlation between HAD scale and CCSS scale. Minimal scale = 0, maximal scale = 42. Higher score means worse outcome
-
Severity of post-traumatic stress disorder symptoms
Time frame: at inclusion and month 6
Severity of post-traumatic stress disorder (PTSD) symptoms assessed by the PTSD Checklist for DSM-5 (PCL-5), based on total score and DSM-5 clinical thresholds. Minimal scale = 0, maximal scale = 80. Higher score means worse outcome
-
International Trauma Questionnaire (ITQ).
Time frame: Inclusion and month 6
International Trauma Questionnaire (ITQ), according to ICD-11 criteria. Minimal scale = 0, maximal scale = 72. Higher score means worse outcome
-
Severity of emotional dysregulation
Time frame: inclusion and month 6
Severity of emotional dysregulation assessed using the Difficulties in Emotion Regulation Scale - French version (DERS-F). Minimal scale = 36, maximal scale = 180. Higher score means worse outcome
-
Short Form Health Survey (SF-12)
Time frame: inclusion and month 6
Health-related quality of life assessed using the 12-Item Short Form Health Survey (SF-12), including physical and mental component summary scores. optimal scale more than 40. scale < 40 means worse outcome
-
Brief Pain Inventory
Time frame: at inclusion and month 6
Pain intensity and functional impact assessed using the Brief Pain Inventory (BPI). mninimal scale = 0, maximal scale = 10. Higher score means worse outcome
-
Coercive Control Scale (CCSS)
Time frame: inclusion and month 6
Analysis of score distribution on the Coercive Control Scale (CCSS) to determine a clinically relevant threshold for coercive control. Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
-
Woman Abuse Screening Tool (WAST)
Time frame: inclusion and month 6
Intimate partner violence assessed using the Woman Abuse Screening Tool (WAST). minimal scale = 0, maximal scale = 16. Higher score means worse outcome
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Intercommunal Robert Ballanger
Other
Registry information
Official study title
Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes
Acronym: CCVCS
Important dates
- Study start
- 2026
- Primary completion
- 2028
- Study completion
- 2028
- First posted
- May 11, 2026
- Registry last updated
- May 26, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.